Mary Nivison

821 total citations
14 papers, 601 citations indexed

About

Mary Nivison is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Mary Nivison has authored 14 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Immunology. Recurrent topics in Mary Nivison's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Immune Response and Inflammation (3 papers) and Alzheimer's disease research and treatments (2 papers). Mary Nivison is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Immune Response and Inflammation (3 papers) and Alzheimer's disease research and treatments (2 papers). Mary Nivison collaborates with scholars based in United States, New Zealand and France. Mary Nivison's co-authors include Thomas J. Montine, Robert F. Hevner, Chris Englund, Diane Pham, Tom Kowalczyk, Ray A. M. Daza, Jean S. Campbell, Kathleen S. Montine, Izumi Maezawa and Nobuyo Maeda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The FASEB Journal.

In The Last Decade

Mary Nivison

13 papers receiving 593 citations

Peers

Mary Nivison
Comparison fields: 5 of 72
  • Molecular Biology 302
  • Neurology 128
  • Developmental Neuroscience 112
  • Hepatology 97
  • Surgery 88
Chandresh R. Gajera United States
P. Anthony Otero United States
Maria Troullinaki Germany
Shuiting Zhai China
Lisa Prichard United States
Dolores Moreno Spain
Peter Gochee Australia
F Stivala Italy
Katharina Berger Germany
Kazuhiko Namikawa Japan
Chandresh R. Gajera United States View profile →
Citations per field, relative to Mary Nivison
Mary Nivison · 1×
Citations per year, relative to Mary Nivison
Mary Nivison · 1×

Countries citing papers authored by Mary Nivison

Since Specialization
Citations

This map shows the geographic impact of Mary Nivison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Nivison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Nivison more than expected).

Fields of papers citing papers by Mary Nivison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Nivison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Nivison. The network helps show where Mary Nivison may publish in the future.

Co-authorship network of co-authors of Mary Nivison

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Nivison. A scholar is included among the top collaborators of Mary Nivison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Nivison. Mary Nivison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
# Title Journal Authors Indexed citations
1 Role for CCN1 in lysophosphatidic acid response in PC‐3 human prostate cancer cells Journal of Cell Communication and Signaling Mary Nivison, Kathryn E. Meier et al. 2
2 Heparin-binding Epidermal Growth Factor-like Growth Factor Links Hepatocyte Priming with Cell Cycle Progression during Liver Regeneration UNC Libraries Claudia Mitchell, Jean S. Campbell et al. 1
3 The synthesis and secretion of versican isoform V3 by mammalian cells: A role for N-linked glycosylation Matrix Biology Ingrid A. Harten, Gernot Kaber et al. 8
4 Effects of Lycopene on Growth Factor Response in Prostate Cancer Cells The FASEB Journal Mary Nivison, Kathryn E. Meier et al. 0
5 The role of CCN4/WISP-1 in the cancerous phenotype Cancer Management and Research Mary Nivison, Kathryn E. Meier 16
6 Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression Experimental Neurology Mary Nivison, Nolan G. Ericson et al. 15
7 Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation Journal of Biological Chemistry Inkyung Kang, Ingrid A. Harten et al. 51
8 Protection of Hippocampal Neurogenesis from Toll-Like Receptor 4-Dependent Innate Immune Activation by Ablation of Prostaglandin E2 Receptor Subtype EP1 or EP2 American Journal Of Pathology C. Dirk Keene, Mary Nivison et al. 29
9 Modulation of Microglial Innate Immunity in Alzheimers Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma Current Medicinal Chemistry Mary Nivison, Thomas J. Montine et al. 36
10 Development of the Deep Cerebellar Nuclei: Transcription Factors and Cell Migration from the Rhombic Lip Journal of Neuroscience Chris Englund, Ray A. M. Daza et al. 185
11 Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK The FASEB Journal Izumi Maezawa, Mary Nivison et al. 92
12 CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2 Dejan Milatović, Snjezana Zaja‐Milatovic et al. 3
13 Acute Ischemic Injury of Astrocytes Is Mediated by Na-K-Cl Cotransport and not Ca2+Influx at a Key Point in White Matter Development Journal of Neuropathology & Experimental Neurology Robert Thomas, Michael G. Salter et al. 39
14 Heparin-binding Epidermal Growth Factor-like Growth Factor Links Hepatocyte Priming with Cell Cycle Progression during Liver Regeneration Journal of Biological Chemistry Claudia Mitchell, Mary Nivison et al. 124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026